Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) is a once-weekly prescription injection licensed in the UK for weight management. In clinical trials it produced an average body-weight reduction of around 15% over 68 weeks, with higher reductions reported at the newer 7.2mg maintenance dose. Private treatment costs vary by dose and provider (typically somewhere in the range of £149–£375 per month) and that figure only tells part of the story. As a prescription-only medicine, Wegovy requires a clinical assessment before any prescription can be issued; what that assessment includes, and what happens after, differs considerably between providers.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks goes something like this: "I've seen Wegovy listed for wildly different prices online — what's the actual cost?" The honest answer is that private pricing in the UK is set per pen, per month, and changes as your dose goes up. Eli Lilly revised Mounjaro's list price in September 2025, and the market for injectable weight-loss medicines more broadly shifted with it; Wegovy prices have followed a similar pattern of variation across providers.
As a rough guide, reported private prices for Wegovy sit somewhere between £149 and £375 per month depending on the dose, with starter doses at the lower end and maintenance doses at the higher. These figures are widely reported and hedged here deliberately: they reflect a market snapshot, not a guarantee of what any individual provider charges. The only price that should matter to you is the one that appears on your provider's treatment page, with everything it includes spelled out clearly. You can read more about the evidence behind Wegovy's results in our overview of weight loss outcomes on Wegovy.
What NICE's appraisal of semaglutide (TA875) and its formal recommendations make clear is that this is a medicine intended for use alongside dietary support and increased activity, not a standalone intervention. That clinical context is part of what you're paying for when pricing is done properly.
A low monthly figure looks compelling. It rarely tells the whole story. Across the UK private market, the following are sometimes excluded from a headline price: the initial consultation fee, the prescription charge, delivery costs, and any clinical support between orders. Some providers charge separately for dose-review appointments or aftercare calls. Add those up over six months and the "cheaper" option frequently isn't.
There's also the question of what happens when something goes wrong. Nausea, fatigue and gastrointestinal symptoms are common in the early weeks of treatment, as the NHS medicines page for semaglutide explains. Access to a prescriber when you need one is not a luxury add-on, it's part of safe use. Check whether aftercare is genuinely available seven days a week, or whether "support" means a contact form.
If you're trying to get a clearer picture of what monthly progress might look like, our page on Wegovy weight loss month by month sets out what the clinical evidence shows at each stage.
We are not the cheapest option. That is a deliberate choice. One price at nume covers your clinical consultation, the prescription, the treatment itself, next-working-day tracked delivery by DPD, and seven-day aftercare, nothing extra, nothing hidden, and no subscription that continues without your say-so. Every repeat order goes through a fresh clinical review; no pen is dispatched on autopilot.
Order before 12pm on a working day and, once approved, your treatment leaves our GPhC-registered pharmacy the same day, arriving the following working day in plain unbranded packaging. Our pharmacy's registration (number 9012878) is publicly verifiable on the GPhC register. If you'd like to know more about who reviews your consultation, our clinical team page sets that out.
You can see current treatment pricing, with nothing obscured, on our Wegovy pricing page.
The MHRA has warned publicly about counterfeit weight-loss pens sold online, seized in large numbers, some containing insulin rather than semaglutide, some causing hospitalisations. Sellers offering these medicines without a clinical assessment are a red flag, not a bargain. Discount codes applied to prescription medicines from unverified sellers are among the clearest warning signs the MHRA points to.
For a prescription-only medicine, the question that keeps you safe isn't "which provider charges least?", it's "which provider can show me their GPhC registration, has a real prescriber reading my notes, and will be reachable if I feel unwell at 8pm on a Saturday?" Those are the things worth comparing. Our individual results guide covers the factors that actually predict outcomes (clinical history, lifestyle, starting dose) rather than leaving you with a headline trial figure and no context.
Wegovy is a prescription-only medicine. Suitability is decided by a prescriber after a proper clinical assessment, not by a checklist. If you want to understand how much weight can realistically be lost on Wegovy, or are curious about how much Wegovy slows down digestion and why that matters for tolerability, both pages give you the clinical detail behind the headlines. If you're ready to find out whether it's right for you, the next step is straightforward.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.